Timing-specific efficacy of antiviral baloxavir and anti-inflammatory oclacitinib monotherapies, and the benefits of their combination in treating influenza in mice.

Front Microbiol · 2026 · PMC13033785 · PMID 41918532

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

did not reach statistical significancep < 0.01actually significant

However, the survival rate of mice treated at 2 and 4 dpi did not reach statistical significance ( p < 0.01) when comparing the entire disease course, but did when comparing the last 18 days of the disease.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.